Share Email Print
cover

Proceedings Paper

Specular reflection vs. backscattering for transdermal OCT-based glucose monitoring with an implantable sensor system
Author(s): Alexander I. Kholodnykh; Ralph Ballerstadt; Adam Boretsky; Colton Evans; Ashok Gowda; Roger McNichols; Massoud Motamedi
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

The reliability of optical techniques for non-invasive monitoring of glucose can be significantly improved by the deployment of a subcutaneous implantable sensor that can closely track the changes in the local concentration of glucose in skin. We have developed a novel implantable sensor that can track glucose-induced changes in the optical turbidity of the implant. In this sensor, optical turbidity decreases significantly with increased glucose concentrations. We performed comparative measurements by optical coherence tomography (OCT) used to monitor backscattering or specular reflection originated from specific structures within the sensor and by collimated light transmission measurement technique to measure the changes in light attenuation as function of glucose concentration within the sensor as well as when the sensor was implanted in phantom media or in tissue samples. These measurements showed that glucose-induced changes in the transmission values derived from OCT monitoring of the sensor turbidity differed up two times from those obtained by collimated transparency measurement (CTM) technique. These results were used to determine the values for scattering coefficients of tissue and the sensor and to estimate the relative loss in sensor sensitivity as a function of implantation depth in tissue. The results suggest that the implantable sensor can be placed in turbid medium such as skin up to an optical depth of 12 mean free paths (mfp), one could expect. For a turbid medium such as skin with a scattering coefficient (µs ) of 10mm-1, this would result in geometrical depth of implantation at 1.2 mm beneath the tissue where sensor sensitivity of 50% or higher is expected. The study demonstrates that it could be feasible to engineer a novel optical sensor for glucose monitoring that can be implanted under the skin while providing a high degree of sensitivity and specificity for non-invasive glucose monitoring.

Paper Details

Date Published: 28 February 2008
PDF: 12 pages
Proc. SPIE 6863, Optical Diagnostics and Sensing VIII, 686306 (28 February 2008); doi: 10.1117/12.763563
Show Author Affiliations
Alexander I. Kholodnykh, The Univ. of Texas Medical Branch at Galveston (United States)
Ralph Ballerstadt, BioTex, Inc. (United States)
Adam Boretsky, The Univ. of Texas Medical Branch at Galveston (United States)
Colton Evans, BioTex, Inc. (United States)
Ashok Gowda, BioTex, Inc. (United States)
Roger McNichols, BioTex, Inc. (United States)
Massoud Motamedi, The Univ. of Texas Medical Branch at Galveston (United States)


Published in SPIE Proceedings Vol. 6863:
Optical Diagnostics and Sensing VIII
Gerard L. Coté; Alexander V. Priezzhev, Editor(s)

© SPIE. Terms of Use
Back to Top